Please login to the form below
Asbestos
This page shows the latest Asbestos news and features for those working in and with pharma, biotech and healthcare.
J&J to FDA: there really is no asbestos in Baby Powder
as other samples from the same manufacturing lost, and has found zero asbestos. ... It was the first time that the US regulator reported finding asbestos in Johnson’s Baby Powder.
Latest news
-
Litigation concerns threaten to overshadow solid quarter at J&J
It has also been hit in the past by lawsuits involving asbestos in talc, hip replacement and vaginal mesh products, some of which are still working their way through the courts.
-
J&J found liable in first opioid mis-marketing verdict
One example is an ongoing battle over whether or not its Baby Powder product contained asbestos, where it is facing thousands of claims, including a class action of claimants saying it
-
Trump’s Brexit trade plan is bad for NHS, say campaigners
The latter could mean that products now banned because they may contain material dangerous to human health – like asbestos fibres – would be allowed to be sold in the UK, it asserts.
-
Blow for J&J as court refuses to overturn talc verdict
including its baby powder, contain asbestos and caused them to develop ovarian cancer. ... finished powders had on occasion tested positive for small amounts of asbestos “from at least 1971 to the early 2000s” and alleges the company was aware of the
-
Biotecnol taps into Cancer Research UK network for first trial
Biotecnol has already prepared the groundwork for trials in mesothelioma, an untreatable and highly-aggressive cancer which is caused by past occupational exposure to asbestos.
Litigation concerns threaten to overshadow solid quarter at J&J
J&J found liable in first opioid mis-marketing verdict
Trump’s Brexit trade plan is bad for NHS, say campaigners
Biotecnol taps into Cancer Research UK network for first trial
More from news
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma companies to watch
Meanwhile, litigation over asbestos in talc continues, with wins and losses for the company in the last few months, with the stand-out verdict a $4.7bn damages award in Missouri ... It has had independent tests conducted on the same bottle and insists
-
The transatlantic opioid crisis
It is a situation analogous with the far reaching use and reliance upon asbestos – something promoted as a wonder material and marketed as such even after its manufacturers allegedly knew of
20 for 2020 – Five pharma companies to watch
The transatlantic opioid crisis
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
My Dad was 'one in a million', as the saying goes. But actually he was one in 300 million (of patients worldwide with rare disease)
It’s caused by inhaling asbestos fibres into the lungs and, shockingly, mesothelioma typically takes 20 to 50 years to develop! ... he contracted meso in the early 70's when working in aircraft hangers, surrounded by asbestos.
-
Rare Disease Day 2018: Five things you should know about rare diseases.
anthrax [4] and rabies [5]), or environmental factors (e.g. malignant peritoneal mesothelioma caused by asbestos exposure [6]). ... Accessed February 2018. 6. Asbestos.com. Peritoneal mesothelioma. Available at: .
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Events Executive
-
Depending on Experience
-
Digital account director
-
Competitive
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Distracted boyfriend: the secret of a successful long-distance relationship
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Vertex gains FDA fast track designation for diabetes stem cell therapy
- Onyx Health Launch Creative Studio After Record Year
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche appoints Philip Atkinson to new global role
- AZ’s comeback drug cediranib stumbles in phase 3 trial
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
